Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized TrialXavier Sáez‐Llorens, Nicolas Vanhoutte, Ximena Norero et al.|The Journal of Infectious Diseases|2023Cited by 13
<scp>HIV</scp> postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta surveyGeorgina Fernandes, Alasdair Bamford, Santa Ansone et al.|HIV Medicine|2024Cited by 7